New hope for Hard-to-Treat blood cancers? early trial of MS-553 begins
Disease control
Not yet recruiting
This early-phase trial is testing an experimental drug called MS-553 in 12 adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to treatment. The main goal is to check the drug's safety and find the right dose…
Phase: PHASE1, PHASE2 • Sponsor: MingSight Pharmaceuticals, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC